Ananth Sastry

Ananth Sastry

Ophthalmology

21 Sugarbush Court
Ashland, OH 44805

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Initial Impact of Loss of Copay Assistance From a National Nonprofit Fund on Outcomes of Retinal Disease.

Initial Impact of Loss of Copay Assistance From a National Nonprofit Fund on Outcomes of Retinal Disease.

Journal: Journal of vitreoretinal diseases

Published: August 26, 2026

Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana Vitrectomy.

Quality Improvement in Vitreoretinal Surgery: Single-Center Report on Utility of Routine Intravenous Fluids in Pars Plana Vitrectomy.

Journal: Journal of vitreoretinal diseases

Published: April 21, 2026

Reply to Comment on: Impact of Phacoemulsification on Vitreomacular Traction Release and Complications.

Reply to Comment on: Impact of Phacoemulsification on Vitreomacular Traction Release and Complications.

Journal: American journal of ophthalmology

Published: March 28, 2026

Reply to Comment on: Impact of Phacoemulsification on Vitreomacular Traction Release and Complications.

Reply to Comment on: Impact of Phacoemulsification on Vitreomacular Traction Release and Complications.

Journal: American journal of ophthalmology

Published: March 28, 2026

ASSOCIATION BETWEEN IRIS MANIPULATION DURING PHACOVITRECTOMY FOR RETINAL DETACHMENT REPAIR AND PROLIFERATIVE VITREORETINOPATHY.

ASSOCIATION BETWEEN IRIS MANIPULATION DURING PHACOVITRECTOMY FOR RETINAL DETACHMENT REPAIR AND PROLIFERATIVE VITREORETINOPATHY.

Journal: Retina (Philadelphia, Pa.)

Published: March 12, 2026

Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema.

Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema.

Journal: Journal of vitreoretinal diseases

Published: October 07, 2025

Combined Preventive and Preconditioning Treatments for the Comorbidity of Alzheimer's Disease and Ischemic Stroke in a GluN3A Knockout Mouse and a 5xFAD Mouse.

Combined Preventive and Preconditioning Treatments for the Comorbidity of Alzheimer's Disease and Ischemic Stroke in a GluN3A Knockout Mouse and a 5xFAD Mouse.

Journal: Cells

Published: September 29, 2025

Impact of Phacoemulsification on Vitreomacular Traction Release and Complications.

Impact of Phacoemulsification on Vitreomacular Traction Release and Complications.

Journal: American journal of ophthalmology

Published: August 27, 2025

Preventive Memantine Treatment at the Preclinical Stage in the Alzheimer's Disease Model of the 5xFAD Mouse.

Preventive Memantine Treatment at the Preclinical Stage in the Alzheimer's Disease Model of the 5xFAD Mouse.

Journal: Neuroscience bulletin

Published: July 27, 2025

Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular Degeneration.

Initial Functional and Anatomical Outcomes of High-dose Aflibercept 8 mg in Exudative Neovascular Age-related Macular Degeneration.

Journal: Ophthalmology. Retina

Published: December 18, 2024

BILATERAL EYE PATCHING MAY IMPROVE CLINICAL OUTCOMES FOR ACUTE PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT.

BILATERAL EYE PATCHING MAY IMPROVE CLINICAL OUTCOMES FOR ACUTE PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT.

Journal: Retina (Philadelphia, Pa.)

Published: November 16, 2023

PROPHYLACTIC TREATMENT OF LATTICE DEGENERATION IN FELLOW EYES AFTER REPAIR OF UNCOMPLICATED PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT.

PROPHYLACTIC TREATMENT OF LATTICE DEGENERATION IN FELLOW EYES AFTER REPAIR OF UNCOMPLICATED PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT.

Journal: Retina (Philadelphia, Pa.)

Published: August 03, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026